Low-dose valaciclovir prophylaxis against cytomegalovirus disease in renal transplant recipients.

Low-dose valaciclovir prophylaxis against cytomegalovirus disease in renal transplant recipients.

High-dose valaciclovir at up to 8 g/day has been shown to be effective in prophylaxis against cytomegalovirus (CMV) disease in renal transplant recipients. We report our experience with low-dose valaciclovir prophylaxis of up to 3 g/day, adjusted to creatinine clearance. A group of patients at high...

Detaylı Bibliyografya
Asıl Yazarlar:	Reddy, S, Handa, A, Tan, L, Devaney, A, Hughes, D, Mason, P, Friend, P, Darby, C
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2003

Benzer Materyaller

Comparison between valganciclovir and aciclovir/valaciclovir for CMV prophylaxis in pediatric renal transplantation
Yazar:: M Fila, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Prophylaxis of Cytomegalovirus in Renal Transplant Recipients
Yazar:: Allan S MacDonald, ve diğerleri
Baskı/Yayın Bilgisi: (1993-01-01)

Donor and recipient CMV serostatus and antigenemia after renal transplantation: an analysis of 486 patients.
Yazar:: Hughes, D, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Resistant cytomegalovirus infection in renal transplant recipients
Yazar:: Benjamin Pei Zhi Cherng, ve diğerleri
Baskı/Yayın Bilgisi: (2015-12-01)

Tuberculosis in Renal Transplant Recipients: The Evidence for Prophylaxis
Yazar:: Currie, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Prevention of Congenital Cytomegalovirus Infection: Review and Case Series of Valaciclovir versus Hyperimmune Globulin Therapy
Yazar:: Giovanni Nigro, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01)

Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience
Yazar:: Linda A. Selvey, ve diğerleri
Baskı/Yayın Bilgisi: (2017-07-01)

Effectiveness of valacyclovir prophylaxis against the occurrence of cytomegalovirus infection in kidney transplant recipients
Yazar:: Woo Yeong Park, ve diğerleri
Baskı/Yayın Bilgisi: (2020-03-01)

Coinfection of BK virus and cytomegalovirus in renal transplant recipients
Yazar:: Rudreshwar Prabakaran, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant Recipients
Yazar:: Nathalie Hammer, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

Lymphocyte subpopulations during cytomegalovirus disease in renal transplant recipients
Yazar:: S.M. Castro, ve diğerleri
Baskı/Yayın Bilgisi: (2003-06-01)

Cytomegalovirus disease in a renal transplant recipient: the importance of pre-transplant screening of the donor and recipient
Yazar:: Ahmed H Mitwalli, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

A single-centre observational study comparing the impact of different cytomegalovirus prophylaxis strategies on cytomegalovirus infections in kidney transplant recipients
Yazar:: Mabel Si Hua Tan, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

The incidence of cytomegalovirus infection in lung transplant recipients under universal prophylaxis with intravenous ganciclovir
Yazar:: Regina Schröeder, ve diğerleri

Cytomegalovirus infection in renal transplant recipients diagnosed by nested-PCR
Yazar:: V.H. Aquino, ve diğerleri
Baskı/Yayın Bilgisi: (2001-01-01)

Cytomegalovirus in renal transplant recipients from living donors with and without valganciclovir prophylaxis and with immunosuppression based on anti-thymocyte globulin or basiliximab
Yazar:: Jorge Andrade-Sierra, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

Rabdomiolisis asociada al tratamiento con valaciclovir
Yazar:: Héctor Enríquez Gómez, ve diğerleri
Baskı/Yayın Bilgisi: (2012-03-01)

Efficacy of Low Dose Valganciclovir Prophylaxis for Cytomegalovirus Infection in Kidney Transplantation
Yazar:: Ümit Özçelik, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Cytomegalovirus infection in transplant recipients
Yazar:: Luiz Sergio Azevedo, ve diğerleri
Baskı/Yayın Bilgisi: (2015-07-01)

Molecular detection and genotyping of Human Cytomegalovirus in kidney transplant recipients under ganciclovir prophylaxis in Iran
Yazar:: Farzane Behnezhad, ve diğerleri
Baskı/Yayın Bilgisi: (2022-07-01)

PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTS
Yazar:: V. V. Ryazhenov, ve diğerleri
Baskı/Yayın Bilgisi: (2011-06-01)

Cytomegalovirus ischemic colitis and transverse myelitis in a renal transplant recipient
Yazar:: Imen Gorsane, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Evaluation of diagnostic tests for cytomegalovirus active infection in renal transplant recipients
Yazar:: Rodrigo Fontanive Franco, ve diğerleri

Cytomegalovirus Infection in Pediatric Renal Transplant Recipients: A Single Center Experience
Yazar:: Mi Jin Kim, ve diğerleri
Baskı/Yayın Bilgisi: (2017-10-01)

Detection of Ganciclovir-Resistant Cytomegalovirus in a Prospective Cohort of Kidney Transplant Recipients Receiving Subtherapeutic Valganciclovir Prophylaxis
Yazar:: Diana D. Wong, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

Cytomegalovirus Infection in Kidney Transplant Recipients
Yazar:: Dino Šisl, ve diğerleri
Baskı/Yayın Bilgisi: (2021-04-01)

Cytomegalovirus DNAemia in kidney transplant recipients after cessation of standard antiviral prophylaxis; estimated rate on Thai cases and implication on efficacy of prophylaxis
Yazar:: Won Sriwijitalai, ve diğerleri
Baskı/Yayın Bilgisi: (2019-05-01)

Direct visualisation of cytomegalovirus-specific CD8+ T cells in renal transplant recipients.
Yazar:: Hilton, R, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Cytomegalovirus infection and unusual early graft dysfunction in a renal transplant recipient
Yazar:: Suzan Sanavi, ve diğerleri
Baskı/Yayın Bilgisi: (2009-01-01)

Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathy
Yazar:: Anupma Kaul, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

Postsurgical skin ulcers caused by cytomegalovirus vasculopathy in a renal transplant recipient
Yazar:: Shikha Rao, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

Prevalence of nonmalignant cutaneous disease in renal transplant recipients
Yazar:: Lally, A, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy
Yazar:: Restelli U, ve diğerleri
Baskı/Yayın Bilgisi: (2019-05-01)

Efficacy of valaciclovir in preventing herpes zoster in patients receiving anifrolumab
Yazar:: Zahir Amoura, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient
Yazar:: Susanne Jung, ve diğerleri
Baskı/Yayın Bilgisi: (2019-05-01)

Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation
Yazar:: Kaiwen Chen, ve diğerleri
Baskı/Yayın Bilgisi: (2018-08-01)

Low dose thymoglobulin versus basiliximab in cytomegalovirus positive kidney transplant recipients: Effectiveness of preemptive cytomegalovirus modified strategy
Yazar:: Camilo Montero, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Low dose thymoglobulin versus basiliximab in cytomegalovirus positive kidney transplant recipients: Effectiveness of preemptive cytomegalovirus modified strategy
Yazar:: Camilo Montero, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Prevention and Treatment of Cytomegalovirus Infection in Transplant Recipients
Yazar:: Jutta K Preiksatis
Baskı/Yayın Bilgisi: (1993-01-01)

Comparison of prophylactic versus preemptive treatments in the management of cytomegalovirus infection in renal transplant recipients
Yazar:: Cengiz Karaçin, ve diğerleri
Baskı/Yayın Bilgisi: (2020-05-01)